facebook

The Most Common Premium IOL Misunderstandings

3 min read

Five misconceptions recur across UK private cataract and lens replacement consultations. Each drives regret. Each is testable against the published evidence, and each fails the test.

The Five Recurring Misconceptions

Misconception 1: EDOF Lenses Do Not Cause Haloes

EDOF reduces the intensity of photic phenomena compared with first-generation multifocals. It does not eliminate them. Haloes, glare, and starbursts are reported by a meaningful proportion of EDOF recipients, particularly in low-light conditions, and the reduction relative to trifocals comes at the cost of reduced near vision.¹

Misconception 2: Premium Lenses Provide Perfect Spectacle Independence

Trifocal lenses deliver the highest likelihood of full glasses-free function, but no lens delivers it for every patient. Patients should expect a high probability of spectacle independence with the right selection, not a guarantee.²

Misconception 3: You Can Always Upgrade Later

Lens exchange is technically possible but is more complex than primary surgery and carries higher risk. Treating exchange as a casual option distorts the upstream decision.

Misconception 4: All Surgeons Offer the Same Outcomes

Outcomes vary substantially across surgeons and across clinics. Experience, volume, audited data, and consultation infrastructure all shape the probability of a satisfactory result. The lens does not perform itself.

Misconception 5: Online Research Is Equivalent to Clinical Assessment

Online research generalises population-level data. It cannot evaluate the individual eye, the individual ocular surface, or the individual personality. The brightest claims surface to the top, and the brightest claims are rarely the most honest.³

Why the Misconceptions Persist

These misconceptions are not random. They are the consequence of marketing narratives surfacing in places that resemble independent advice. Each can be corrected, but only inside a consultation that is willing to correct them.

Who This Is Not For

Patients who would prefer the misconceptions were true. Some of them are very nearly true for some patients. None of them is universally true, and the patients who proceed as if they were are the patients most likely to regret it.

Clinical Takeaway

The five most common misconceptions about premium IOLs are testable against evidence, and each one fails. A consultation worth having is one that surfaces them and corrects them.

References

  1. Cochener B; Concerto Study Group. Clinical outcomes of a new extended range of vision intraocular lens: International Multicenter Concerto Study. J Cataract Refract Surg. 2016;42(9):1268-1275.
  2. Cochener B. Prospective clinical comparison of patient outcomes following implantation of trifocal or bifocal intraocular lenses. J Refract Surg. 2016;32(3):146-151.
  3. Mencucci R, Cennamo M, Venturi D, Vignapiano R, Favuzza E. Visual outcome, optical quality, and patient satisfaction with a new monofocal IOL, enhanced for intermediate vision: preliminary results. J Cataract Refract Surg. 2020;46(3):378-387.

Related Topics

About Blue Fin Vision®

Blue Fin Vision® is a GMC-registered, consultant-led ophthalmology clinic with CQC-regulated facilities across London, Hertfordshire, and Essex. Patient outcomes are independently audited by the National Ophthalmology Database, confirming exceptionally low complication rates.